Mallinckrodt Receives Court Approval For “First Day” Motions To Support Ongoing Operations
Mallinckrodt plc (OTC:MNKTQ) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has received approvals from the U.S. Bankruptcy Court for the